Antibodies Elicited by the First Non-Viral Prophylactic Cancer Vaccine Show Tumor-Specificity and Immunotherapeutic Potential

Scientific Reports - United Kingdom
doi 10.1038/srep31740
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effectiveness of Measles, Mumps and Rubella Vaccine as Immunotherapeutic Agent for Cutaneous Viral Warts

International Journal of Research in Dermatology
2020English

Immunotherapeutic Cell-Based Vaccine to Combat Metastatic Breast Cancer

2000English

Vaccine Trials for the Clinician: Prospects for Viral and Non‐Viral Vectors

Oncologist
Cancer ResearchMedicineOncology
1997English

Chimeric Hepatitis B Virus/Hepatitis C Virus Envelope Proteins Elicit Broadly Neutralizing Antibodies and Constitute a Potential Bivalent Prophylactic Vaccine

Hepatology
MedicineHepatology
2013English

Cancer Immunotherapeutic Potential of Novel Small Molecule TLR7 and TLR8 Agonists

Journal of Immunotoxicology
ToxicologyImmunology
2009English

Specificity of Monoclonal Antibodies Elicited by Mucosal Infection of BALB/c Mice With Virulent Shigella Flexneri 2a.

Clinical and diagnostic laboratory immunology
1996English

Targeting Non-Viral Vectors to Tumor Cells and the Tumor Microenvironment

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2010English

T Cell Costimulatory Molecules in Anti-Viral Immunity: Potential Role in Immunotherapeutic Vaccines

Canadian Journal of Infectious Diseases
2003English

A Milk-Based Self-Assemble Rotavirus VP6–ferritin Nanoparticle Vaccine Elicited Protection Against the Viral Infection

Journal of Nanobiotechnology
Applied MicrobiologyMolecular MedicineNanosciencePharmaceutical ScienceMedicineBiotechnologyBioengineeringBiomedical EngineeringNanotechnology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy